The level of AFP-L3 in serum will increase linearly with the growth of hepatocellular carcinoma, which has a relatively high specificity for the diagnosis of liver cancer, and it will not be restricted by the rule of AFP ≥ 400 μg/L. Here, AFP is linked to liver cancer.